Skin lymphomatous lesions treated by rituximab: a necrotic life-threatening evolution.
Védrine
Lionel
L
Fromatin
Isabelle
I
Vincent-Salomon
Anne
A
Decaudin
Didier
D
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005075:Biological Evolution; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000473:pathology; D009336:Necrosis; D000069283:Rituximab; D012871:Skin Diseases / Q000150:complications / Q000473:pathology*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab